Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem
12:02pm, Thursday, 20'th May 2021
3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem
Repligen (RGEN) Enters Oversold Territory
07:31am, Monday, 17'th May 2021
Repligen (RGEN) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
The Power of a Great System
02:04pm, Friday, 14'th May 2021
The current system has created a tremendous wealth gap in America. Which is why I've decided to tackle it head on.
With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market
06:40am, Friday, 07'th May 2021
One company is setting itself apart in a crowded field.
Repligen Corporation's (RGEN) CEO Tony Hunt on Q1 2021 Results - Earnings Call Transcript
02:55pm, Tuesday, 04'th May 2021
Repligen Corporation's (RGEN) CEO Tony Hunt on Q1 2021 Results - Earnings Call Transcript
Repligen (RGEN) Beats on Q1 Earnings & Sales, Raises 2021 View
01:32pm, Tuesday, 04'th May 2021
Repligen (RGEN) reports encouraging first-quarter results with sales and earnings beating estimates. The company also raises its guidance for 2021.
RGEN Stock: From $208.11 To $216.50 (4.03% Increase) Pre-Market Explanation
09:02am, Tuesday, 04'th May 2021
The stock price of Repligen Corporation (NASDAQ: RGEN) increased from $208.11 to $216.50 (up 4.03%) pre-market. This is why it happened.
Repligen to Report First Quarter 2021 Financial Results
07:30am, Tuesday, 20'th Apr 2021
Webcast and Conference Call to Be Held Tuesday, May 4, 2021 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, May 4, 2021 at 8:30 a.m. EDT
7 Big Names That Could Be the Next Tesla
10:41am, Wednesday, 07'th Apr 2021
These names are major disruptors in their respective industries. Could one of them be the next Tesla?
3 Disruptive Stocks to Buy and Hold for the Next Decade
06:11am, Sunday, 28'th Mar 2021
These companies are set to keep riding upward thanks to long-term secular trends.
Why Is Repligen (RGEN) Down 12.9% Since Last Earnings Report?
12:07pm, Friday, 26'th Mar 2021
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Is Repligen (RGEN) a Great Growth Stock?
09:51am, Thursday, 25'th Mar 2021
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Repligen (RGEN).
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
07:30am, Wednesday, 17'th Mar 2021
WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virt
Repligen Corporation to Present at Barclays Global Healthcare Conference
07:30am, Wednesday, 03'rd Mar 2021
WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virt
Repligen (RGEN) Q4 Earnings & Sales Top, 2021 Outlook Bright
09:08am, Thursday, 25'th Feb 2021
Repligen (RGEN) reports encouraging fourth-quarter results with sales and earnings beating estimates. The company's guidance for 2021 also beats market expectations.
